Table of Contents Author Guidelines Submit a Manuscript
Advances in Pharmacological Sciences
Volume 2012, Article ID 529861, 2 pages

G A B A 𝐀 Receptor Subtypes: Novel Targets for Novel Medicines

1Neuro Search A/S, Pederstrupvej 93, 2750 Ballerup, Denmark
2Johnson & Johnson Pharmaceutical Research and Development, 30 Turnhoutseweg, B-2340 Beerse, Belgium
3Eli Lilly UK, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK

Received 14 December 2011; Accepted 14 December 2011

Copyright © 2012 Naheed R. Mirza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [2 citations]

The following is the list of published articles that have cited the current article.

  • Robert P. Bonin, “Restoring ionotropic inhibition as an analgesic strategy,” Neuroscience Letters, vol. 557, pp. 43–51, 2013. View at Publisher · View at Google Scholar
  • J M Witkin, J M Schkeryantz, K R Methuku, J M Cook, M M Poe, R Cerne, M Wakulchik, J S, S D Gleason, T M Jones, G Li, L A Arnold, and J-X Li, “Further evaluation of the potential anxiolytic activity of imidazo[1,5-a][1,4]diazepin agents selective for α2/3-containing GABAA receptors.,” Pharmacology, biochemistry, and behavior, vol. 157, pp. 35–40, 2017. View at Publisher · View at Google Scholar